MedCity News August 14, 2019
Highmark is turning its internal VITAL Innovation program into a commercial offering meant to help startups test their products in real-world clinical environments.
Even if healthcare technology startups survive the venture capital valley of death, what may finish them off later is commercialization and the hurdles presented by reimbursement and slow adoption.
One purchaser of health tech has devised a path to test and validate new innovations by generating the clinical and economic evidence that startups need for a positive coverage approval from insurers and adoption by clinicians.
Pittsburgh-based integrated health system Highmark created its VITAL Innovation Program in 2015 to use the organization’s resources as a way to test FDA-approved technologies internally.
VITAL is organized under the overarching Highmark...
Today's Sponsors
Today's Sponsor